GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML) Trademark

Trademark Overview


On Friday, September 21, 2018, a trademark application was filed for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML) with the United States Patent and Trademark Office. The USPTO has given the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML) trademark a serial number of 88127445. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 10, 2021. This trademark is owned by Sun Pharmaceutical Industries Limited. The GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML) trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
gemcitabine in 0.9% sodium chloride injection mg per ml (10 mg/ml)

General Information


Serial Number88127445
Word MarkGEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)
Filing DateFriday, September 21, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 10, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 29, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION MG PER ML (10 MG/ML)"
Description of MarkThe mark consists of a rectangle surrounding the word "GEMCITABINE" above the words "in 0.9% sodium chloride injection" along with an arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle, with the words "mg per mL (10 mg/mL)".
Goods and Servicesmedicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Goods and Servicesmedical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code010
First Use Anywhere DateWednesday, July 8, 2020
First Use In Commerce DateWednesday, July 8, 2020

Trademark Owner History


Party NameSun Pharmaceutical Industries Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Party NameSun Pharmaceutical Industries Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMumbai, Maharashtra 400063
IN

Trademark Events


Event DateEvent Description
Monday, May 10, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 10, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 22, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 22, 2020NON-FINAL ACTION E-MAILED
Thursday, October 22, 2020SU - NON-FINAL ACTION - WRITTEN
Thursday, October 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 24, 2020USE AMENDMENT FILED
Wednesday, September 30, 2020EXTENSION 3 GRANTED
Thursday, September 24, 2020EXTENSION 3 FILED
Wednesday, September 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 24, 2020TEAS EXTENSION RECEIVED
Thursday, September 24, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, March 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 24, 2020EXTENSION 2 GRANTED
Tuesday, March 24, 2020EXTENSION 2 FILED
Tuesday, March 24, 2020TEAS EXTENSION RECEIVED
Wednesday, September 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2019EXTENSION 1 GRANTED
Monday, September 23, 2019EXTENSION 1 FILED
Monday, September 23, 2019TEAS EXTENSION RECEIVED
Tuesday, March 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 21, 2018ASSIGNED TO LIE
Friday, November 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 29, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, November 29, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, November 29, 2018EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Saturday, September 29, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 25, 2018NEW APPLICATION ENTERED IN TRAM